← back to database
Catalio Capital Management is a global, multi-strategy specialist investor focused on breakthrough biomedical technology and healthcare companies. Its platform invests across company stages, sizes, and the capital structure through private, public-equity, and credit strategies.
Stage focus
Lead / follow
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$2B AUM
Investing team
Ajay ManthaPartner
Ben SnedekerPartner & Head of Public Equities
Brian Malik, Ph.D.Senior Analyst
Collin Spencer, Ph.D.Associate
Constantine AlexosAnalyst
David Stonko, M.D.Clinical Associate
Diamantis Xylas, M.D.Partner & Head of Research
George C. PetrocheilosCo-Founder & Managing Partner
Hai Yan, Ph.D.Partner
Isaac RoPartner
John Henry Iucker, CFAPartner & Head of Credit
Matthew Hobson, Ph.D.Principal
Nicholas von Guionneau, M.D.Principal
Pasquale ChiacchiariPrincipal & Head of Data Science
R. Jacob Vogelstein, Ph.D.Co-Founder & Managing Partner
Sean WangPrincipal
Tom BrooksPartner
Trent MurphyAnalyst
Vicky SostilioVice President, North America
Will DenehyVice President, Europe